Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX3CER
|
||||
| Drug Name |
3-(4-(2-methoxyphenyl)piperazin-1-yl)-1-(4-nitrophenyl)propan-1-ol
|
||||
| Synonyms |
CHEMBL135961
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C20H25N3O4
|
||||
| Canonical SMILES |
COc1ccccc1N2CCN(CCC(O)c3ccc(cc3)[N+](=O)[O-])CC2
|
||||
| InChI |
InChI=1S/C20H25N3O4/c1-27-20-5-3-2-4-18(20)22-14-12-21(13-15-22)11-10-19(24)16-6-8-17(9-7-16)23(25)26/h2-9,19,24H,10-15H2,1H3
|
||||
| InChIKey |
OSWCBMIHTMACBP-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.